Snehal Patel is CEO and CFO of Greenwich LifeSciences, Inc.. Currently has a direct ownership of 5.6 Million shares of GLSI, which is worth approximately $46.9 Million. The most recent transaction as insider was on Nov 19, 2020, when has been sold 2,000 shares (Common Stock) at a price of $5.4 per share, resulting in proceeds of $10,800. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.6M
0.52% 3M change
0.84% 12M change
Total Value Held $46.9 Million

Snehal Patel Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 19 2020
BUY
Open market or private purchase
$10,800 $5.4 p/Share
2,000 Added 0.17%
1,186,839 Common Stock
Sep 29 2020
BUY
Open market or private purchase
$76,668 $4.6 p/Share
16,667 Added 1.39%
1,184,839 Common Stock
Sep 29 2020
BUY
Exercise of conversion of derivative security
-
304,489 Added 20.68%
1,168,172 Common Stock
SP

Snehal Patel

CEO and CFO
Stafford, TX

Track Institutional and Insider Activities on GLSI

Follow Greenwich LifeSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GLSI shares.

Notify only if

Insider Trading

Get notified when an Greenwich Life Sciences, Inc. insider buys or sells GLSI shares.

Notify only if

News

Receive news related to Greenwich LifeSciences, Inc.

Track Activities on GLSI